How do I start a norepinephrine (noradrenaline) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Start a Norepinephrine Drip

Norepinephrine is the first-choice vasopressor for septic shock and should be started immediately after adequate fluid resuscitation, targeting a mean arterial pressure (MAP) of 65 mmHg. 1, 2

Preparation and Dilution

Standard concentration: Add 4 mg (one 4 mL vial) of norepinephrine to 1,000 mL of 5% dextrose solution to yield 4 mcg/mL 3

  • Must dilute in dextrose-containing solutions (D5W or D5NS) - dextrose protects against oxidation and potency loss
  • Do NOT use saline alone as the diluent 3
  • Alternative concentration for pump use: 1 mg in 100 mL saline yields 10 mcg/mL (easier for titration)

Access and Administration

Preferred Route: Central Venous Access

  • Insert a plastic IV catheter through a large bore needle, advanced centrally into the vein 3
  • Secure with adhesive tape; avoid tie-in techniques that promote stasis
  • Essential equipment: IV drip chamber or metering device for accurate flow rate monitoring 3

Peripheral Administration (When Central Access Delayed)

Peripheral norepinephrine is safe when following strict protocols - this can avoid central line placement in 50% of patients 4

Protocol requirements for peripheral use:

  • 18-gauge or larger catheter 5
  • Site: At or above the antecubital fossa, or external jugular vein 5
  • Maximum dose: 20 mcg/min peripherally 5
  • Maximum duration: Less than 24 hours 6, 4
  • Monitoring: Visual inspection and evaluation every 2 hours 6
  • Extravasation rate: 2-4.5% with protocol adherence, minimal tissue injury when treated promptly 6, 5, 7

Critical caveat: Peripheral administration should be viewed as a bridge to central access or for short-duration use only. The extravasation risk, while low with protocols, can cause tissue injury if not monitored meticulously.

Initial Dosing

Starting dose: 2-3 mL/min of the standard dilution (8-12 mcg/min) 3

Alternative dosing approach:

  • Start at 0.5-1 mL/min (2-4 mcg/min) and titrate upward 3
  • Using an infusion pump: 30-100 mL/h (5-15 mcg/min) of the 1:100,000 solution 8

Titration and Monitoring

Target MAP: 65 mmHg 1, 2

  • In previously hypertensive patients, raise BP no higher than 40 mmHg below pre-existing systolic pressure 3

Maintenance dosing:

  • Average: 2-4 mcg/min (0.5-1 mL/min of standard dilution) 3
  • Range: Can titrate from 1-4 mcg/min up to maximum 10 mcg/min 8
  • High doses (up to 68 mg/day or 17 vials) occasionally necessary, but always suspect occult blood volume depletion at high doses 3

Essential monitoring:

  • Arterial catheter placement as soon as practical 1, 2
  • Continuous hemodynamic monitoring in ICU setting 8
  • If invasive monitoring unavailable: every-minute BP and pulse measurements plus ECG monitoring 8

Critical Pre-requisites

Before starting norepinephrine:

  1. Fluid resuscitation first: Minimum 30 mL/kg crystalloids (normal saline preferred) 2

    • Adults: 1-2 L at 5-10 mL/kg in first 5 minutes 8
    • May require up to 7 L total 8
  2. Concurrent supportive measures:

    • Oxygen administration: 6-8 L/min 8
    • Patient positioning: Recumbent with elevated lower extremities 8
    • Airway management if needed 8

Exception: In emergency situations where cerebral or coronary ischemia is imminent, norepinephrine can be started before complete volume resuscitation, but fluid replacement must continue concurrently 3

Extravasation Management

If extravasation occurs:

  • Phentolamine: 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL normal saline, injected intradermally at extravasation site 9, 7
  • Plus nitroglycerin paste applied locally 7
  • This combination effectively prevents local ischemic injury 7

When to Add Additional Agents

If MAP target not achieved with norepinephrine alone:

  • Add vasopressin 0.03 units/min (not as sole initial agent) 1, 2
  • Or add epinephrine (weak recommendation) 1, 2
  • Avoid dopamine except in highly selected patients with bradycardia and low tachyarrhythmia risk 1, 2

Common pitfall: Do not use low-dose dopamine for "renal protection" - this is ineffective and not recommended 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.